152 related articles for article (PubMed ID: 33871014)
1. Hyperactivity is a Core Endophenotype of Elevated Neuregulin-1 Signaling in Embryonic Glutamatergic Networks.
Götze T; Soto-Bernardini MC; Zhang M; Mießner H; Linhoff L; Brzózka MM; Velanac V; Dullin C; Ramos-Gomes F; Peng M; Husseini H; Schifferdecker E; Fledrich R; Sereda MW; Willig K; Alves F; Rossner MJ; Nave KA; Zhang W; Schwab MH
Schizophr Bull; 2021 Aug; 47(5):1409-1420. PubMed ID: 33871014
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK.
Kotzadimitriou D; Nissen W; Paizs M; Newton K; Harrison PJ; Paulsen O; Lamsa K
eNeuro; 2018; 5(2):. PubMed ID: 29740596
[TBL] [Abstract][Full Text] [Related]
3. NRG1-ErbB4 signaling promotes functional recovery in a murine model of traumatic brain injury via regulation of GABA release.
Deng W; Luo F; Li BM; Mei L
Exp Brain Res; 2019 Dec; 237(12):3351-3362. PubMed ID: 31720762
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice.
Wehr MC; Hinrichs W; Brzózka MM; Unterbarnscheidt T; Herholt A; Wintgens JP; Papiol S; Soto-Bernardini MC; Kravchenko M; Zhang M; Nave KA; Wichert SP; Falkai P; Zhang W; Schwab MH; Rossner MJ
EMBO Mol Med; 2017 Oct; 9(10):1448-1462. PubMed ID: 28743784
[TBL] [Abstract][Full Text] [Related]
5. Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.
O'Tuathaigh CM; Fumagalli F; Desbonnet L; Perez-Branguli F; Moloney G; Loftus S; O'Leary C; Petit E; Cox R; Tighe O; Clarke G; Lai D; Harvey RP; Cryan JF; Mitchell KJ; Dinan TG; Riva MA; Waddington JL
Schizophr Bull; 2017 Jan; 43(1):214-225. PubMed ID: 27613806
[TBL] [Abstract][Full Text] [Related]
6. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
Papaleo F; Yang F; Paterson C; Palumbo S; Carr GV; Wang Y; Floyd K; Huang W; Thomas CJ; Chen J; Weinberger DR; Law AJ
J Neurosci; 2016 Apr; 36(17):4859-75. PubMed ID: 27122041
[TBL] [Abstract][Full Text] [Related]
7. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
Deng C; Pan B; Engel M; Huang XF
Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
[TBL] [Abstract][Full Text] [Related]
9. Structural Similarities between Neuregulin 1-3 Isoforms Determine Their Subcellular Distribution and Signaling Mode in Central Neurons.
Vullhorst D; Ahmad T; Karavanova I; Keating C; Buonanno A
J Neurosci; 2017 May; 37(21):5232-5249. PubMed ID: 28432142
[TBL] [Abstract][Full Text] [Related]
10. Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice.
Deakin IH; Law AJ; Oliver PL; Schwab MH; Nave KA; Harrison PJ; Bannerman DM
Neuroreport; 2009 Nov; 20(17):1523-8. PubMed ID: 19829162
[TBL] [Abstract][Full Text] [Related]
11. TrkB interacts with ErbB4 and regulates NRG1-induced NR2B phosphorylation in cortical neurons before synaptogenesis.
Pandya CD; Pillai A
Cell Commun Signal; 2014 Jul; 12():47. PubMed ID: 25052836
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model.
Schneider S; Götz K; Birchmeier C; Schwegler H; Roskoden T
Behav Brain Res; 2017 Mar; 322(Pt A):177-185. PubMed ID: 28089851
[TBL] [Abstract][Full Text] [Related]
13. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling.
Fazzari P; Paternain AV; Valiente M; Pla R; Luján R; Lloyd K; Lerma J; Marín O; Rico B
Nature; 2010 Apr; 464(7293):1376-80. PubMed ID: 20393464
[TBL] [Abstract][Full Text] [Related]
14. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.
Savonenko AV; Melnikova T; Laird FM; Stewart KA; Price DL; Wong PC
Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5585-90. PubMed ID: 18385378
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice.
Dominguez SL; Hegde GV; Hanson JE; Xiang H; Mandikian D; Boswell CA; Chiu C; Wu Y; Tsai SP; Fleck D; Weber M; Ngu H; Scearce-Levie K; Jackson EL
Sci Rep; 2018 May; 8(1):8239. PubMed ID: 29844389
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine.
Wang N; Zhang GF; Liu XY; Sun HL; Wang XM; Qiu LL; Yang C; Yang JJ
J Mol Neurosci; 2014; 54(2):211-8. PubMed ID: 24633675
[TBL] [Abstract][Full Text] [Related]
17. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons.
Ting AK; Chen Y; Wen L; Yin DM; Shen C; Tao Y; Liu X; Xiong WC; Mei L
J Neurosci; 2011 Jan; 31(1):15-25. PubMed ID: 21209185
[TBL] [Abstract][Full Text] [Related]
19. Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice.
Luo X; He W; Hu X; Yan R
Biol Psychiatry; 2014 Jul; 76(2):120-7. PubMed ID: 24210810
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain.
Deng C; Pan B; Hu CH; Han M; Huang XF
Psychiatry Res; 2015 Feb; 225(3):347-54. PubMed ID: 25576368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
